Benchmark Holdings (BMK)

Sector:

Pharma and Biotech

45.00p
   
  • Change Today:
    -0.50p
  • 52 Week High: 48.00
  • 52 Week Low: 34.00
  • Currency: UK Pounds
  • Shares Issued: 739.67m
  • Volume: 126,760
  • Market Cap: £332.85m

Dividend Data

  30-Sep-2330-Sep-2230-Sep-2130-Sep-2030-Sep-19
Total Dividendn/an/an/an/an/a
For more dividend details, click here

Fundamentals - based on IFRS

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Income Statement 30-Sep-23 30-Sep-22 30-Sep-21 30-Sep-20 30-Sep-19
Continuing Operations          
Revenue 169.48 157.71 125.06 105.57 124.01
Operating Profit/(Loss) (5.32) (6.23) (5.38) (11.02) 46.84
Net Interest (7.38) (15.15) (3.80) (11.70) (12.05)
Profit Before Tax (12.69) (21.38) (9.18) (22.57) (58.48)
Profit After Tax (16.06) (28.65) (11.58) (22.77) (59.12)
Discontinued Operations          
Profit After Tax (5.51) (1.80) n/a (9.17) (23.96)
PROFIT FOR THE PERIOD (21.56) (30.45) (11.58) (31.95) (83.08)
Attributable to:          
Equity Holders of Parent Company (21.56) (30.45) (12.89) (32.92) (83.86)
Minority Interests n/a n/a 1.32 0.97 0.78
           
Continuing EPS          
Earnings per Share - Basic (2.41p) (4.34p) (1.93p) (3.80p) (10.72p)
Earnings per Share - Diluted (2.41p) (4.34p) (1.93p) (3.80p) (10.72p)
Earnings per Share - Adjusted (2.41p) (4.34p) (1.93p) (3.80p) (10.72p)
Continuing and Discontinued EPS          
Earnings per Share - Basic (3.16p) (4.60p) (1.93p) (5.26p) (15.01p)
Earnings per Share - Diluted (3.16p) (4.60p) (1.93p) (5.26p) (15.01p)
Earnings per Share - Adjusted (3.16p) (4.60p) (1.93p) (5.26p) (15.01p)
           
Dividend per Share n/a n/a n/a n/a n/a
  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Balance Sheet 30-Sep-23 30-Sep-22 30-Sep-21 30-Sep-20 30-Sep-19
Assets          
Non-Current Assets          
Property, Plant & Equipment 93.21 108.93 104.31 75.95 88.90
Intangible Assets 206.08 245.26 229.04 247.00 275.74
Investment Properties n/a n/a n/a n/a n/a
Investments 0.01 0.01 0.01 0.02 0.03
Other Financial Assets n/a n/a n/a n/a n/a
Other Non-Current Assets 21.96 23.99 24.60 20.31 15.92
  321.27 378.20 357.96 343.29 380.59
Current Assets          
Inventories 25.27 29.81 20.95 18.93 22.61
Trade & Other Receivables 59.79 56.38 46.50 39.37 52.14
Cash at Bank & in Hand 36.53 36.40 39.46 71.61 16.05
Current Asset Investments n/a n/a n/a n/a n/a
Other Current Assets 27.59 25.78 17.12 15.85 31.99
  149.17 148.37 124.03 145.75 122.79
           
Other Assets 0.85 n/a n/a n/a n/a
Total Assets 471.30 526.57 481.99 489.04 503.38
           
Liabilities          
Current Liabilities          
Borrowings 20.05 17.09 10.65 5.34 3.23
Other Current Liabilities 55.03 56.17 52.87 50.04 48.98
  75.08 73.26 63.52 55.37 52.21
           
Net Current Assets cn/a cn/a cn/a cn/a cn/a
           
Non-Current Liabilities          
Borrowings 81.95 93.04 109.74 103.82 99.96
Provisions 24.81 27.99 28.22 32.65 38.74
Other Non-Current Liabilities 6.84 9.00 0.91 1.75 2.00
  113.60 130.03 138.87 138.22 140.71
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 188.68 203.29 202.39 193.60 192.91
           
Net Assets 282.62 323.29 279.60 295.44 310.47
           
Capital & Reserves          
Share Capital 0.74 0.70 0.67 0.67 0.56
Share Premium Account n/a n/a 400.68 n/a n/a
Other Reserves 92.18 497.83 (160.10) 430.63 414.68
Retained Earnings 183.49 (185.14) 30.47 (142.17) (110.92)
Shareholders Funds 276.40 313.40 271.71 289.13 304.33
           
Minority Interests/Other Equity 6.21 9.89 7.88 6.31 6.14
Total Equity 282.62 323.29 279.60 295.44 310.47
Cash Flow 30-Sep-23 30-Sep-22 30-Sep-21 30-Sep-20 30-Sep-19
Net Cash Flow From Operating Activities 20.00 10.81 5.79 (4.06) (9.21)
Returns On Investment & Servicing of Finance fn/a fn/a fn/a fn/a fn/a
Taxation Paid fn/a fn/a fn/a fn/a fn/a
Net Cash Flow from Investing Activities (5.27) (11.22) (23.09) 30.38 (15.32)
Acquisitions & Disposals gn/a gn/a gn/a gn/a gn/a
Dividends Paid fn/a fn/a fn/a fn/a fn/a
Management of Liquid Resources cn/a cn/a cn/a cn/a cn/a
Net Cash Flow from Financing Activities (12.33) (6.92) (14.67) 30.13 15.98
Net Increase/Decrease In Cash 2.41 (7.33) (31.97) 56.45 (8.55)
Ratios - based on IFRS 30-Sep-23 30-Sep-22 30-Sep-21 30-Sep-20 30-Sep-19
Continuing Operations          
PE Ratio - Adjusted n/a n/a n/a n/a n/a
PEG - Adjusted n/a n/a n/a n/a n/a
Earnings per Share Growth - Adjusted n/a n/a n/a n/a n/a
Dividend Cover n/a n/a n/a n/a n/a
Revenue per Share 22.91p 21.32p 0.17p 14.27p 16.77p
Pre-Tax Profit per Share (1.72p) (2.89p) (0.013p) (3.05p) (7.91p)
Operating Margin (3.14%) (3.95%) (4.30%) (10.44%) 37.77%
Return on Capital Employed n/a n/a n/a n/a n/a
Continuing & Discontinued Operations          
PE Ratio - Adjusted n/a n/a n/a n/a n/a
PEG - Adjusted n/a n/a n/a n/a n/a
Earnings per Share Growth - Adjusted n/a n/a n/a n/a n/a
Dividend Cover n/a n/a n/a n/a n/a
           
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a n/a n/a
Operating Cash Flow per Share 2.71p 1.46p 0.78p (0.55p) (1.25p)
Cash Incr/Decr per Share 0.33p (0.99p) (0.044p) 7.63p (1.16p)
Net Asset Value per Share (exc. Intangibles) 10.35p 10.55p 6.83p 6.55p 4.69p
Net Gearing 23.69% 23.53% 29.79% 12.99% 28.63%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: Forecast figures based on normalised accounts.

 

Top of Page